Rehovot, Israel

Ruth Lieshitz

This inventor holds 1 USPTO granted patent. Top assignee: Bio-Technology General Corporation. Active years: 1994.


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 1994

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Ruth Lieshitz: Innovator in Biochemical Purification

Introduction

Ruth Lieshitz is a prominent inventor based in Rehovot, Israel. She has made significant contributions to the field of biochemistry, particularly in the purification of enzymes. Her innovative work has led to the development of a patented method that enhances the recovery of valuable biochemical compounds.

Latest Patents

Ruth Lieshitz holds a patent for a "Method for purification of recombinant copper/zinc (Cu-Zn) superoxide." This invention provides a method for recovering a solution containing purified, enzymatically active Cu-Zn superoxide dismutase or a polypeptide analog thereof. The method is designed to extract these compounds from a composition that includes cells containing Cu-Zn superoxide dismutase or its analogs. Additionally, her invention offers a way to increase the yield of recovered solutions with a higher concentration of the enzymatically active polypeptide analog.

Career Highlights

Throughout her career, Ruth has been associated with Bio-Technology General Corporation, where she has applied her expertise in biochemical research. Her work has not only advanced scientific understanding but has also contributed to practical applications in biotechnology.

Collaborations

Ruth has collaborated with notable colleagues, including Daniel Bartfeld and Dany Hadary. These partnerships have fostered a collaborative environment that enhances innovation and research outcomes.

Conclusion

Ruth Lieshitz is a trailblazer in the field of biochemical purification, with a focus on enhancing the recovery of important enzymes. Her contributions through her patent and collaborations continue to impact the biotechnology industry positively.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…